Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
16-30 of 124
Christophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
The Evidence Base: Key Trials and Emerging Data
MinuteCE®The Evidence Base: Key Trials and Emerging Data
Christophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
From Data to Decision: Patient Selection and Real-World Application
MinuteCE®From Data to Decision: Patient Selection and Real-World Application
Christophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
The Case for Change: Why Perioperative Immunotherapy Matters in LA HNSCC
MinuteCE®The Case for Change: Why Perioperative Immunotherapy Matters in LA HNSCC
Christophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
Building the Team: Integrating Immunotherapy Into Multidisciplinary Care
MinuteCE®Building the Team: Integrating Immunotherapy Into Multidisciplinary Care
Christophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
MinuteCE®From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
Aditya Bardia, MD, MPH, FASCO
Erica L. Mayer, MD, MPH
- advertisement
Cracking the Code: Risk Stratification Guidelines to Identify High-Risk Patients
MinuteCE®Cracking the Code: Risk Stratification Guidelines to Identify High-Risk Patients
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Precision in Practice—Bringing Targeted Therapy to mHSPC
MinuteCE®Precision in Practice—Bringing Targeted Therapy to mHSPC
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
The Power of Timing: Therapies That Change Outcomes
MinuteCE®The Power of Timing: Therapies That Change Outcomes
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
ADT Intensification in Biochemically Recurrent Prostate Cancer: When to Act
MinuteCE®ADT Intensification in Biochemically Recurrent Prostate Cancer: When to Act
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Tiffany Traina, MD
Comparing First-Line TROP2-Directed ADCs in Metastatic TNBC: Latest Clinical Evidence
MinuteCE®Comparing First-Line TROP2-Directed ADCs in Metastatic TNBC: Latest Clinical Evidence
Javier Cortes, MD, PhD
- advertisement
Tiffany Traina, MD
Javier Cortes, MD, PhD
Managing Adverse Events Associated With TROP2-Directed ADCs in Metastatic TNBC
MinuteCE®Managing Adverse Events Associated With TROP2-Directed ADCs in Metastatic TNBC
Tiffany Traina, MD
Translating Evidence on TROP2-Directed ADCs Into Global Practice in Metastatic TNBC
MinuteCE®Translating Evidence on TROP2-Directed ADCs Into Global Practice in Metastatic TNBC
Tiffany Traina, MD
Javier Cortes, MD, PhD
